15.74

3.53% -0.5558

Cogent Biosciences Inc (COGT)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Cogent Biosciences Inc stock is traded at $15.74, with a volume of 1.70M. It is down -3.53% in the last 24 hours and down -0.22% over the past month. Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.

Previous Close:

$16.30

Open:

$16.25

24h Volume:

1.70M

Relative Volume:

0.94

Market Cap:

$1.79B

Revenue:

Net Income/Loss:

$-284.08M

P/E Ratio:

-6.4967

EPS:

-2.4234

Net Cash Flow:

$-234.65M

1W Performance:

-2.93%

1M Performance:

-0.22%

6M Performance:

+167.89%

1Y Performance:

+34.17%

1-Day Range:

$15.71

$16.75

1-Week Range:

$15.71

$16.75

52-Week Range:

$3.72

$17.15

Cogent Biosciences Inc Stock (COGT) Company Profile

Name

Cogent Biosciences Inc

Sector

Healthcare (1139)

Industry

Biotechnology (635)

Phone

617-945-5576

Address

275 WYMAN STREET, WALTHAM

Employee

205

Twitter

Next Earnings Date

2024-10-31

Latest SEC Filings

COGT's Discussions on Twitter

Compare COGT with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
COGT Cogent Biosciences Inc	15.74	2.28B	0	-284.08M	-234.65M	-2.4234
VRTX Vertex Pharmaceuticals Inc	425.76	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.33	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	432.40	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	821.30	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	184.16	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Cogent Biosciences Inc Stock (COGT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Oct-16-25	Initiated	Stifel	Hold
Sep-03-25	Initiated	Raymond James	Strong Buy
Mar-07-25	Initiated	Scotiabank	Sector Outperform
Dec-11-24	Downgrade	Needham	Buy → Hold
Feb-26-24	Downgrade	Robert W. Baird	Outperform → Neutral
Feb-08-24	Initiated	Citigroup	Buy
Dec-11-23	Downgrade	Wedbush	Outperform → Neutral
Dec-08-23	Initiated	JP Morgan	Overweight
Apr-28-23	Initiated	Robert W. Baird	Outperform
Mar-27-23	Resumed	H.C. Wainwright	Buy
Dec-14-22	Initiated	Needham	Buy
Jun-28-22	Initiated	Guggenheim	Buy
Oct-11-21	Initiated	H.C. Wainwright	Buy
Jun-09-21	Resumed	Jefferies	Buy
Dec-23-20	Initiated	Piper Sandler	Overweight
Oct-14-20	Initiated	Ladenburg Thalmann	Buy

View All

Cogent Biosciences Inc Stock (COGT) Latest News

10:41 AM

Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2025 Financial Results - Investing News Network

10:41 AM

10:35 AM

Cogent Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener

10:35 AM

10:27 AM

Cogent Biosciences (COGT): Anticipated Data Releases and Strategic Advancements - GuruFocus

10:27 AM

Cogent Biosciences (COGT) Boosts Financial Position with Strong Cash Reserves - GuruFocus

10:27 AM

09:09 AM

Cogent Biosciences posts wider Q3 loss as costs rise - MarketScreener

09:09 AM

09:03 AM

Cogent Biosciences Announces Multiple Presentations at the 67th Annual American Society of Hematology (ASH) Meeting - The Manila Times

09:03 AM

Cogent Biosciences Spends Big As Drug Hopes Build - Finimize

09:03 AM

09:01 AM

Cogent Biosciences (NASDAQ: COGT) expects Phase 3 PEAK Nov and APEX Dec readouts - Stock Titan

09:01 AM

09:00 AM

Cogent Bio (NASDAQ: COGT) to present NonAdvSM bezuclastinib, JAK2 V617F poster at ASH - Stock Titan

09:00 AM

06:37 AM

How Cogent Biosciences Inc. stock benefits from tech adoptionRisk Management & Consistent Profit Alerts - newser.com

06:37 AM

06:30 AM

Candlestick signals on Cogent Biosciences Inc. stock todayJuly 2025 Momentum & Reliable Intraday Trade Plans - newser.com

06:30 AM

04:16 AM

What high frequency data says about Cogent Biosciences Inc.Portfolio Gains Report & Fast Gain Stock Trading Tips - newser.com

04:16 AM

03:17 AM

How Cogent Biosciences Inc. stock performs in high volatility marketsJuly 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com

03:17 AM

01:31 AM

What earnings revisions data tells us about Cogent Biosciences Inc.Bond Market & Weekly High Potential Stock Alerts - newser.com

01:31 AM

01:07 AM

Why Cogent Biosciences Inc. stock remains resilientIPO Watch & Target Return Focused Stock Picks - newser.com

01:07 AM

Nov 02, 2025

Is Cogent Biosciences Inc. stock a buy before product launches2025 Institutional Moves & Weekly Setup with High ROI Potential - newser.com

Nov 02, 2025

Will Cogent Biosciences Inc. stock benefit from upcoming earnings reportsMarket Risk Analysis & Real-Time Stock Entry Alerts - newser.com

Nov 02, 2025

How strong is Cogent Biosciences Inc. stock revenue growthBear Alert & Community Trade Idea Sharing - newser.com

Nov 02, 2025

Published on: 2025-11-02 00:56:21 - newser.com

Nov 02, 2025

Nov 01, 2025